Stay updated on GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.

Latest updates to the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s revision label was updated from v3.5.3 to v3.5.4, indicating a new software build. This change does not modify study information or user-facing features beyond the version badge.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page has been updated to revision v3.5.3, replacing v3.5.2, indicating a minor maintenance release for the page. This change does not alter the study content or key information presented on the page.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2; v3.5.2 was added and v3.5.0 removed. This updates the page version without changing the study details or user-facing content.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page.SummaryDifference0.1%

- Check79 days agoChange DetectedFooter now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check107 days agoChange DetectedThe page now shows Revision: v3.4.2; the previous Revision: v3.4.1 and the government funding lapse notice were removed.SummaryDifference0.4%

Stay in the know with updates to GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.